N85.00 Endometrial hyperplasia, unspecified

Name of the Condition

• Endometrial hyperplasia, unspecified

Summary

Endometrial hyperplasia, unspecified, refers to abnormal thickening of the uterine lining (endometrium) without a specified subtype. This condition involves excessive cell growth and may increase the risk of endometrial cancer if left untreated. It is often linked to hormonal imbalances and requires evaluation to determine the appropriate management.

Causes

The primary cause is an imbalance between estrogen and progesterone, where estrogen promotes endometrial growth without sufficient progesterone to counteract it. This imbalance can result from conditions like anovulation, obesity, or exogenous hormone use. In some cases, the exact cause remains unclear.

Risk Factors

• Obesity, which increases estrogen production
• Anovulatory cycles or polycystic ovary syndrome (PCOS)
• Estrogen-only hormone therapy without progesterone
• Late menopause or early menarche
• History of infertility or nulliparity
• Diabetes or hypertension

Symptoms

• Abnormal uterine bleeding (e.g., heavy or prolonged periods)
• Spotting between menstrual cycles
• Postmenopausal bleeding (in older women)
• Pelvic pain or pressure (less common)

Diagnosis

Diagnosis typically involves a transvaginal ultrasound to assess endometrial thickness and an endometrial biopsy to evaluate cellular changes. Additional tests, such as hysteroscopy or hormonal assays, may be used to rule out other conditions or confirm the diagnosis.

Treatment Options

Treatment depends on the severity and may include progesterone therapy to regulate the endometrium, hormonal intrauterine devices (IUDs), or surgical intervention like dilation and curettage (D&C) for severe cases. Regular monitoring is often recommended to prevent progression.

Prognosis and Follow-Up

With appropriate treatment, the prognosis is generally favorable, especially for simple hyperplasia. Follow-up may involve repeat biopsies or imaging to ensure resolution and monitor for recurrence. Complex or atypical hyperplasia carries a higher risk of progression to cancer, requiring more aggressive management.

Complications

• Progression to endometrial cancer, particularly with atypical hyperplasia
• Persistent abnormal bleeding affecting quality of life
• Anemia from chronic blood loss

Lifestyle & Prevention

• Maintain a healthy weight to reduce estrogen excess
• Use combination hormone therapy (estrogen plus progesterone) if needed
• Manage underlying conditions like PCOS or diabetes
• Avoid unopposed estrogen use without medical guidance

When to Seek Professional Help

Seek care for persistent abnormal bleeding, postmenopausal bleeding, or pelvic pain. Early evaluation is crucial for at-risk individuals, such as those with obesity or hormonal imbalances, to prevent complications.

Tips for Medical Coders

Document the clinical findings and diagnostic methods used to confirm the diagnosis. Ensure the code N85.00 is applied when the hyperplasia is unspecified and not further classified. Include details about biopsy results or imaging findings to support the coding choice, as these may influence subsequent management and coding accuracy.